August 12, 2021
W Health leads investment into BeatO
DEAL BRIEF
W Health Global Series LLC (“W Health Ventures”), along with other investors, led the Pre-Series B investment round of approx. USD 5.7 million in Health Arx Technologies Private Limited (undertaking business as BeatO). BeatO offers services to patients with diabetes through a smartphone glucometer and mobile application, which connects them with in-house specialists, shares and analyses readings, tracks fitness levels, and manages the diet of the patient with a range of diabetic-friendly food products. W Health Ventures is a Boston-based venture capital firm focused on helping entrepreneurs build the future of healthcare.
OUR ROLE
We, at Nishith Desai Associates, acted as the India legal counsel to W Health Ventures. We advised them on the legal, tax and regulatory aspects of the transaction.
NEWS AND MEDIA REPORTS RELATED TO THE DEAL
https://www.vccircle.com/w-health-ventures-pharmeasy-others-invest-in-diabetes-management-app-beato/
https://inc42.com/buzz/beato-raises-inr-42-cr-funding-from-w-health-ventures-pharmeasy/